{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:08:39Z","timestamp":1789754919670,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB0940000"],"award-info":[{"award-number":["XDB0940000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82394452"],"award-info":[{"award-number":["82394452"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1303200"],"award-info":[{"award-number":["2022YFA1303200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2408085JX013"],"award-info":[{"award-number":["2408085JX013"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.it.2026.08.012","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:31:48Z","timestamp":1789417908000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Spatially instructed checkpoints in antitumor NK cell immunity"],"prefix":"10.1016","author":[{"given":"Ruifeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2026.08.012_bb0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.it.2026.08.012_bb0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2026.08.012_bb0015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40164-025-00633-8","article-title":"The clinical landscape of CAR NK cells","volume":"14","author":"Jorgensen","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.it.2026.08.012_bb0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12943-022-01672-z","article-title":"NK cells and solid tumors: therapeutic potential and persisting obstacles","volume":"21","author":"Tong","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.it.2026.08.012_bb0025","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41573-022-00413-7","article-title":"Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders","volume":"21","author":"Maskalenko","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2026.08.012_bb0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41586-023-06945-1","article-title":"Natural killer cell therapies","volume":"626","author":"Vivier","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.it.2026.08.012_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adn1849","article-title":"Metabolic programs drive function of therapeutic NK cells in hypoxic tumor environments","volume":"10","author":"Kennedy","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.it.2026.08.012_bb0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/s41590-025-02178-8","article-title":"Targeting lactylation reinforces NK cell cytotoxicity within the tumor microenvironment","volume":"26","author":"Jin","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0045","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0050","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andre","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejca.2021.09.003","article-title":"A phase II study of monalizumab in patients with recurrent\/metastatic squamous cell carcinoma of the head and neck: the I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial","volume":"158","author":"Galot","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.it.2026.08.012_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010584","article-title":"TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial","volume":"13","author":"Naing","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.it.2026.08.012_bb0065","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2026.08.012_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.it.2026.08.012_bb0075","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13058-025-01964-4","article-title":"Natural killer cells occupy unique spatial neighborhoods in HER2\u2212 and HER2+ human breast cancers","volume":"27","author":"Ehlers","year":"2025","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.it.2026.08.012_bb0080","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1038\/s41590-024-01943-5","article-title":"Mapping spatial organization and genetic cell-state regulators to target immune evasion in ovarian cancer","volume":"25","author":"Yeh","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0085","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","article-title":"Single-cell spatial landscapes of the lung tumour immune microenvironment","volume":"614","author":"Sorin","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.it.2026.08.012_bb0090","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/ni.3688","article-title":"Early transcriptional and epigenetic regulation of CD8+ T cell differentiation revealed by single-cell RNA sequencing","volume":"18","author":"Kakaradov","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0095","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/s41590-026-02471-0","article-title":"Targeting NK cell CLEC12B enhances cancer immunotherapy","volume":"27","author":"Sun","year":"2026","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0100","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/s41467-026-68661-4","article-title":"SAMSN1 restrains NK cell mediated anti-tumor immunity in hepatocellular carcinoma","volume":"17","author":"Wang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2026.08.012_bb0105","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/eji.201545835","article-title":"Microenvironmental stresses induce HLA-E\/Qa\u22121 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells","volume":"46","author":"Sasaki","year":"2016","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0110","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccell.2023.01.001","article-title":"Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance","volume":"41","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/2159-8290.CD-23-0519","article-title":"NKG2A is a therapeutic vulnerability in immunotherapy resistant MHC-I heterogeneous triple-negative breast cancer","volume":"14","author":"Taylor","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2026.08.012_bb0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41586-019-1485-8","article-title":"Mechanosensation of cyclical force by PIEZO1 is essential for innate immunity","volume":"573","author":"Solis","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.it.2026.08.012_bb0125","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abb5168","article-title":"Targeting Piezo1 unleashes innate immunity against cancer and infectious disease","volume":"5","author":"Aykut","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0130","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41551-024-01188-5","article-title":"PIEZO1 mechanically regulates the antitumour cytotoxicity of T lymphocytes","volume":"8","author":"Pang","year":"2024","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.it.2026.08.012_bb0135","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ccell.2021.10.009","article-title":"Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification","volume":"39","author":"Leader","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0140","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/s41590-024-01884-z","article-title":"Pan-cancer profiling of tumor-infiltrating natural killer cells through transcriptional reference mapping","volume":"25","author":"Netskar","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0145","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.cell.2023.07.034","article-title":"A pan-cancer single-cell panorama of human natural killer cells","volume":"186","author":"Tang","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0150","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41467-024-44789-z","article-title":"Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity","volume":"15","author":"Dean","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2026.08.012_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adw5567","article-title":"CD39+CD49a+CD103+ cytotoxic tissue-resident natural killer cells infiltrate and control solid epithelial tumor growth in mice","volume":"18","author":"Horowitz","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.it.2026.08.012_bb0160","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2021.12.004","article-title":"Discovering dominant tumor immune archetypes in a pan-cancer census","volume":"185","author":"Combes","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0165","doi-asserted-by":"crossref","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","article-title":"Spatially organized multicellular immune hubs in human colorectal cancer","volume":"184","author":"Pelka","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0170","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1038\/s41467-021-26974-6","article-title":"Immune cell topography predicts response to PD-1 blockade in cutaneous T cell lymphoma","volume":"12","author":"Phillips","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2026.08.012_bb0175","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1158\/2159-8290.CD-21-1357","article-title":"The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution","volume":"12","author":"Nirmal","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2026.08.012_bb0180","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.it.2026.08.012_bb0185","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2026.08.012_bb0190","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1158\/2159-8290.CD-24-1208","article-title":"Cytotoxic NK cells impede response to checkpoint immunotherapy in melanoma with an immune-excluded phenotype","volume":"15","author":"Pozniak","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2026.08.012_bb0195","doi-asserted-by":"crossref","first-page":"9464","DOI":"10.1038\/s41467-025-64531-7","article-title":"Tissue localization of natural killer cells dictates surveillance of lung metastasis","volume":"16","author":"Vermeer","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2026.08.012_bb0200","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/s41591-024-03215-z","article-title":"A multi-modal single-cell and spatial expression map of metastatic breast cancer biopsies across clinicopathological features","volume":"30","author":"Klughammer","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2026.08.012_bb0205","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41467-024-47068-z","article-title":"Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer","volume":"15","author":"Croizer","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2026.08.012_bb0210","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-21-0137","article-title":"The ratio of exhausted to resident infiltrating lymphocytes is prognostic for colorectal cancer patient outcome","volume":"9","author":"Foroutan","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.it.2026.08.012_bb0215","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1158\/2326-6066.CIR-18-0500","article-title":"A gene signature predicting natural killer cell infiltration and improved survival in melanoma patients","volume":"7","author":"Cursons","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.it.2026.08.012_bb0220","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gutjnl-2024-332837","article-title":"Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma","volume":"74","author":"Salie","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.it.2026.08.012_bb0225","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.it.2026.08.012_bb0230","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pages","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.it.2026.08.012_bb0235","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41586-025-08668-x","article-title":"Spatial immune scoring system predicts hepatocellular carcinoma recurrence","volume":"640","author":"Jia","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.it.2026.08.012_bb0240","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01659","article-title":"Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells","volume":"3","author":"Sojka","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.it.2026.08.012_bb0245","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/nri.2016.34","article-title":"Emerging insights into natural killer cells in human peripheral tissues","volume":"16","author":"Bjorkstrom","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0250","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2018.09.009","article-title":"High-dimensional single-cell analysis identifies organ-specific signatures and conserved NK cell subsets in humans and mice","volume":"49","author":"Crinier","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.it.2026.08.012_bb0255","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cell.2020.01.022","article-title":"Tissue determinants of human NK cell development, function, and residence","volume":"180","author":"Dogra","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0260","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.immuni.2023.11.018","article-title":"Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection","volume":"57","author":"Torcellan","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.it.2026.08.012_bb0265","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.ccell.2025.05.011","article-title":"Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling","volume":"43","author":"Nikolic","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0270","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2503259122","article-title":"Cancer cells suppress NK cell activity by actin-driven polarization of inhibitory ligands to the immunological synapse","volume":"122","author":"Hoffmann","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2026.08.012_bb0275","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41590-023-01462-9","article-title":"Tumors evade immune cytotoxicity by altering the surface topology of NK cells","volume":"24","author":"Zheng","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0280","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj3286","article-title":"When killers become thieves: trogocytosed PD-1 inhibits NK cells in cancer","volume":"8","author":"Hasim","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.it.2026.08.012_bb0285","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer-natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.it.2026.08.012_bb0290","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"Bottcher","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0295","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0300","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1016\/j.cell.2025.06.027","article-title":"Glucose restriction shapes pre-metastatic innate immune landscapes in the lung through exosomal TRAIL","volume":"188","author":"Wu","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0305","doi-asserted-by":"crossref","first-page":"32005","DOI":"10.1073\/pnas.2015343117","article-title":"Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells","volume":"117","author":"Eisinger","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2026.08.012_bb0310","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","article-title":"Single-cell and spatial transcriptomics analysis of non-small cell lung cancer","volume":"15","author":"De Zuani","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.it.2026.08.012_bb0315","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.it.2026.08.012_bb0320","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/2326-6066.CIR-24-0421","article-title":"The spatial organization of cDC1 with CD8+ T cells is critical for the response to immune checkpoint inhibitors in patients with melanoma","volume":"13","author":"Gobbini","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.it.2026.08.012_bb0325","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1158\/2159-8290.CD-24-0131","article-title":"Cancer-associated fibroblasts serve as decoys to suppress NK cell anticancer cytotoxicity in breast cancer","volume":"15","author":"Ben-Shmuel","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.it.2026.08.012_bb0330","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/s41577-025-01248-0","article-title":"Biochemical signals from the extracellular matrix in inflammation and tumour immunology","volume":"26","author":"Sorokin","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0335","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2026.08.012_bb0340","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.it.2026.08.012_bb0345","first-page":"435","article-title":"Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC","volume":"7","author":"Greenwald","year":"2026","journal-title":"Nat. Can."},{"key":"10.1016\/j.it.2026.08.012_bb0350","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/jamaoncol.2019.1549","article-title":"Comparison of biomarker modalities for predicting response to PD-1\/PD-L1 checkpoint blockade: a systematic review and meta-analysis","volume":"5","author":"Lu","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.it.2026.08.012_bb0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000538344","article-title":"Challenges and opportunities for the clinical translation of spatial transcriptomics technologies","volume":"4","author":"Smith","year":"2024","journal-title":"Glomerul. Dis."},{"key":"10.1016\/j.it.2026.08.012_bb0360","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000155","article-title":"The society for immunotherapy of cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation","volume":"8","author":"Taube","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.it.2026.08.012_bb0365","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008875","article-title":"Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing","volume":"13","author":"Taube","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.it.2026.08.012_bb0370","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012280","article-title":"Society for Immunotherapy of Cancer: standards for reporting of multiplex immunohistochemistry\/immunofluorescence assays (STORMI)","volume":"13","author":"Sater","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.it.2026.08.012_bb0375","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/s41590-026-02473-y","article-title":"Engineering NK and T cells with metabolite-sensing receptors to target solid tumors","volume":"27","author":"Kim","year":"2026","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2026.08.012_bb0380","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/s41587-022-01626-2","article-title":"Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123","volume":"41","author":"Gauthier","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.it.2026.08.012_bb0385","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/s41423-024-01176-4","article-title":"Bridging the gap with multispecific immune cell engagers in cancer and infectious diseases","volume":"21","author":"Rolin","year":"2024","journal-title":"Cell. Mol. Immunol."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490626002280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471490626002280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:36:47Z","timestamp":1789753007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471490626002280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":77,"alternative-id":["S1471490626002280"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2026.08.012","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatially instructed checkpoints in antitumor NK cell immunity","name":"articletitle","label":"Article Title"},{"value":"Trends in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.it.2026.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}